From a monoaminergic point of view, studies in mice showed that PER2 acts as a positive factor in the regulation of monoamine oxidase A gene expression (MaoA) in the ventral tegmental area (VTA) and the striatum [53, 54], which could potentially affect the metabolism of serotonin and neurobiology of depression. Here, MAOA is linked to depressive symptom measurement.